title: [Industrialization of regenerative medicine in Japan].
abstract: Recently, regenerative medicine has attracted attention worldwide and also in Japan. Several guidelines on regenerative medicine have been released from the Japanese regulatory agency. Within the guidelines, Japan Tissue Engineering Co., Ltd. has been developing tissue-engineered products of cultured epidermis, cartilage and cornea using autologous cells. In this paper, we describe the industrialization of regenerative medicine as well as regulations based on our experiences of the culture cartilage development.
authors.affiliation: Japan Tissue Engineering Co., Ltd., Research and Development.
authors.forename: Katsura
authors.initials: K
authors.lastname: Sugawara
authors.forename: Ken-ichiro
authors.initials: K
authors.lastname: Hata
mesh_terms: D000818:Animals; D002356:Cartilage; D002986:Clinical Trials as Topic; D019981:Health Care Sector / Q000331:legislation & jurisprudence; D006801:Humans; D007564:Japan; D011786:Quality Control; D044968:Regenerative Medicine / Q000331:legislation & jurisprudence; D012449:Safety; D023822:Tissue Engineering / Q000331:legislation & jurisprudence